ATE82857T1 - Interleukin-2-zusammensetzungen. - Google Patents

Interleukin-2-zusammensetzungen.

Info

Publication number: ATE82857T1
Authority: AT; Austria
Prior art keywords: interleukin; compositions; useful; treatment; showing
Prior art date: 1986-01-07

Application number

AT87100067T

Other languages

English (en)

Inventor

David R Thatcher

Kazuhiro Shima

Original Assignee

Shionogi & Co

Biogen Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-07

Filing date

1987-01-05

Publication date

1992-12-15

1987-01-05 Application filed by Shionogi & Co, Biogen Nv filed Critical Shionogi & Co

1992-12-15 Application granted granted Critical

1992-12-15 Publication of ATE82857T1 publication Critical patent/ATE82857T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT87100067T 1986-01-07 1987-01-05 Interleukin-2-zusammensetzungen. ATE82857T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP61001846A JPH0645551B2 (ja)	1986-01-07	1986-01-07	インタ−ロイキン−２組成物
EP87100067A EP0229016B1 (de)	1986-01-07	1987-01-05	Interleukin-2-Zusammensetzungen

Publications (1)

Publication Number	Publication Date
ATE82857T1 true ATE82857T1 (de)	1992-12-15

Family

ID=11512913

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87100067T ATE82857T1 (de)	1986-01-07	1987-01-05	Interleukin-2-zusammensetzungen.

Country Status (8)

Country	Link
EP (1)	EP0229016B1 (de)
JP (1)	JPH0645551B2 (de)
KR (1)	KR960012064B1 (de)
AT (1)	ATE82857T1 (de)
CA (1)	CA1288340C (de)
DE (2)	DE3782828T2 (de)
ES (1)	ES2043609T3 (de)
GR (1)	GR3006807T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4992271A (en) *	1982-09-23	1991-02-12	Cetus Corporation	Formulation for lipophilic IL-2 proteins
DE3621828A1 (de) *	1986-06-28	1988-01-14	Biotest Pharma Gmbh	Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
US5037644A (en) *	1986-10-27	1991-08-06	Cetus Corporation	Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
EP0284249A1 (de) *	1987-03-13	1988-09-28	Interferon Sciences, Inc.	Gefriergetrocknete Lymphokin-Zusammensetzung
JPH0676332B2 (ja) *	1988-03-09	1994-09-28	大塚製薬株式会社	インターロイキン‐１βの安定化組成物
JP2799483B2 (ja) *	1988-03-09	1998-09-17	大塚製薬株式会社	インターロイキン−１β組成物の安定化方法
US5078997A (en) *	1988-07-13	1992-01-07	Cetus Corporation	Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
ZA902663B (en) *	1989-04-07	1991-12-24	Syntex Inc	Interleukin-1 formulation
JP2818834B2 (ja) *	1991-08-12	1998-10-30	大塚製薬株式会社	ＩＬ−１α安定化医薬製剤
FR2684878B1 (fr) *	1991-12-12	1994-02-11	Roussel Uclaf	Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
WO1995030412A1 (fr) *	1994-05-06	1995-11-16	Kanebo Limited	Potentialisateur de cytokine et remede pour des maladies dans lesquelles l'activite de la cytokine est reduite
WO1999018119A1 (fr) *	1997-10-03	1999-04-15	Shionogi & Co., Ltd.	Procede de lyophilisation de proteines
PT1491208E (pt)	1999-10-04	2010-05-12	Novartis Vaccines & Diagnostic	Composições farmacêuticas contendo polipéptido líquidas estabilizadas
US6689353B1 (en) *	2000-06-28	2004-02-10	Bayer Pharmaceuticals Corporation	Stabilized interleukin 2
PT1463751E (pt)	2001-12-21	2013-08-26	Human Genome Sciences Inc	Proteínas de fusão de albumina
SI1599222T1 (sl)	2003-01-08	2009-08-31	Novartis Vaccines & Diagnostic	Stabilizirani vodni sestavki, ki obsegajo inhibitor poti tkivnega faktorja (TFPI) ali varianto inhibitorja poti tkivnega faktorja
DE10348550A1 (de) *	2003-10-20	2005-06-16	Hexal Biotech Forschungsgmbh	Stabile wässrige G-CSF-haltige Zusammensetzungen
CN101837119B (zh) *	2010-05-19	2012-07-04	山东东阿阿胶股份有限公司	白介素-11半成品溶液的制备方法及其产品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4462940A (en) *	1982-09-23	1984-07-31	Cetus Corporation	Process for the recovery of human β-interferon-like polypeptides
EP0211835B1 (de) *	1984-03-28	1990-01-03	Cetus Corporation	Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2
JPS60222424A (ja) *	1985-01-25	1985-11-07	Takeda Chem Ind Ltd	インタ−ロイキン−２組成物
DE3583880D1 (de) *	1984-04-09	1991-10-02	Takeda Chemical Industries Ltd	Stabile interleukin-2-zusammensetzung.
US4816440A (en) *	1985-09-26	1989-03-28	Cetus Corporation	Stable formulation of biologically active proteins for parenteral injection

1986
- 1986-01-07 JP JP61001846A patent/JPH0645551B2/ja not_active Expired - Lifetime
- 1986-12-31 CA CA000526570A patent/CA1288340C/en not_active Expired - Lifetime
1987
- 1987-01-05 AT AT87100067T patent/ATE82857T1/de not_active IP Right Cessation
- 1987-01-05 EP EP87100067A patent/EP0229016B1/de not_active Expired - Lifetime
- 1987-01-05 ES ES87100067T patent/ES2043609T3/es not_active Expired - Lifetime
- 1987-01-05 DE DE8787100067T patent/DE3782828T2/de not_active Expired - Lifetime
- 1987-01-05 DE DE198787100067T patent/DE229016T1/de active Pending
- 1987-01-07 KR KR1019870000056A patent/KR960012064B1/ko not_active IP Right Cessation
1993
- 1993-01-14 GR GR930400062T patent/GR3006807T3/el unknown

Also Published As

Publication number	Publication date
GR3006807T3 (de)	1993-06-30
ES2043609T3 (es)	1994-01-01
DE229016T1 (de)	1988-01-14
CA1288340C (en)	1991-09-03
KR960012064B1 (ko)	1996-09-12
EP0229016B1 (de)	1992-12-02
EP0229016A3 (en)	1988-10-05
DE3782828D1 (de)	1993-01-14
DE3782828T2 (de)	1993-04-29
EP0229016A2 (de)	1987-07-15
KR870006901A (ko)	1987-08-13
JPS62164631A (ja)	1987-07-21
JPH0645551B2 (ja)	1994-06-15

Legal Events

Date	Code	Title
1993-05-15	EEIH	Change in the person of patent owner
1993-09-15	UEP	Publication of translation of european patent specification
2005-05-15	EEIH	Change in the person of patent owner
2007-04-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE82857T1 (de)	1992-12-15	Interleukin-2-zusammensetzungen.
DK631688A (da)	1989-05-13	2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
ATE100098T1 (de)	1994-01-15	Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
DE3869007D1 (de)	1992-04-16	Oxydation von alkanen.
DE69024862D1 (de)	1996-02-29	Modifiziertes, biologisch aktives Protein
TR23424A (tr)	1989-12-29	1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri
DE3876997D1 (de)	1993-02-04	Konjugate von superoxiddismutase.
IT8720200A0 (it)	1987-04-22	Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
MC1884A1 (fr)	1989-01-24	Variants de l'hirudine,leur utilisation et leur preparation
DK0401896T3 (da)	1993-11-15	Carboplatinmateriale
TR23373A (tr)	1989-12-28	N'-suebstitueye-n,n'-diasilhidrazinlerin 5 ueyeli heterosiklik tuerevleri
ATE45675T1 (de)	1989-09-15	Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE3781017D1 (de)	1992-09-17	Cytotoxische zusammensetzung aus "killer"-zellen.
FI872232A0 (fi)	1987-05-21	Avlaegsnande av klor ur alkalimetallklorid-vattenloesning.
DE3775457D1 (de)	1992-02-06	Herabsetzung von sphaerolithen in polyamiden.
DK301288A (da)	1988-12-04	Stabile uracilpraeparater
ES556171A0 (es)	1987-08-16	Perfeccionamientos introducidos en la patente de invencion n 531.563
IT8622051A0 (it)	1986-10-17	Composizioni farmaceutiche adattivita' cicatrizzante.
DE3750358D1 (de)	1994-09-15	Acylierungsprodukte von 9,10-Anthracendicarboxaldehyd-bis-(2-imidazolin-2-yl-hydrazonen).
NO875146D0 (no)	1987-12-09	Overflateaktive midler.
KR880009390U (ko)	1988-07-22	때밀이구
IT8683372A0 (it)	1986-06-16	Forbice per bambini.
TR23120A (tr)	1989-04-03	Ensektisid olarak kullanilabilen n'-suebstituee edilmis-n-asil-n'-hidrazinler
ES294084Y (es)	1987-05-16	Mesa
BR6600541U (pt)	1987-11-10	Mesa